U S PHYSICAL THERAPY INC /NV Operating Lease, Payments
U S PHYSICAL THERAPY INC /NV (USPH) reported Operating Lease, Payments of $13.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV operating lease, payments for the quarter ending 2026-06-30 was $13.17M, a 8.09% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV operating lease, payments for the quarter ending 2026-03-31 was $13.04M, a 9.65% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV operating lease, payments for the quarter ending 2025-12-31 was $12.96M, a 13.73% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV operating lease, payments for the quarter ending 2025-09-30 was $12.42M, a 16.73% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV operating lease, payments for fiscal 2025 was $49.45M, a 15.19% increase from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV operating lease, payments for fiscal 2024 was $42.93M, a 7.84% increase from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV operating lease, payments for fiscal 2023 was $39.81M, a 10.18% increase from fiscal 2022.
- U S PHYSICAL THERAPY INC /NV operating lease, payments for fiscal 2022 was $36.14M, a 8.87% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13.17M 10-Q · filed 2026-08-07 | $26.21M 10-Q · filed 2026-08-07 | $39.17M derived: sum of 3 quarters · filed 2026-08-07 | $51.59M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $13.04M 10-Q · filed 2026-05-08 | $26.00M derived: sum of 2 quarters · filed 2026-05-08 | $38.41M derived: sum of 3 quarters · filed 2026-05-08 | $50.60M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $12.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $25.38M derived: sum of 2 quarters · filed 2026-02-27 | $37.56M derived: sum of 3 quarters · filed 2026-08-07 | $49.45M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $12.42M 10-Q · filed 2025-11-07 | $24.61M derived: sum of 2 quarters · filed 2026-08-07 | $36.50M 10-Q · filed 2025-11-07 | $47.89M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | $12.19M 10-Q · filed 2026-08-07 | $24.08M 10-Q · filed 2026-08-07 | $35.47M derived: sum of 3 quarters · filed 2026-08-07 | $46.11M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $11.89M 10-Q · filed 2026-05-08 | $23.29M derived: sum of 2 quarters · filed 2026-05-08 | $33.92M derived: sum of 3 quarters · filed 2026-05-08 | $44.49M derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $11.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $22.03M derived: sum of 2 quarters · filed 2026-02-27 | $32.60M derived: sum of 3 quarters · filed 2026-02-27 | $42.93M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $10.64M 10-Q · filed 2025-11-07 | $21.20M derived: sum of 2 quarters · filed 2025-11-07 | $31.54M 10-Q · filed 2025-11-07 | $41.93M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | $10.56M 10-Q · filed 2025-08-08 | $20.90M 10-Q · filed 2025-08-08 | $31.30M derived: sum of 3 quarters · filed 2026-02-27 | $41.30M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | $10.34M 10-Q · filed 2025-05-09 | $20.73M derived: sum of 2 quarters · filed 2026-02-27 | $30.74M derived: sum of 3 quarters · filed 2026-02-27 | $40.49M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2023-12-31 | $10.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $20.40M derived: sum of 2 quarters · filed 2026-02-27 | $30.16M derived: sum of 3 quarters · filed 2026-02-27 | $39.81M 10-K · filed 2026-02-27 | ||
| 2023-09-30 | $10.01M 10-Q · filed 2024-11-08 | $19.76M derived: sum of 2 quarters · filed 2024-11-08 | $29.42M 10-Q · filed 2024-11-08 | $38.84M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-06-30 | $9.75M 10-Q · filed 2024-08-14 | $19.40M 10-Q · filed 2024-08-14 | $28.84M derived: sum of 3 quarters · filed 2025-03-03 | $37.98M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-03-31 | $9.65M 10-Q · filed 2024-05-08 | $19.09M derived: sum of 2 quarters · filed 2025-03-03 | $28.22M derived: sum of 3 quarters · filed 2025-03-03 | $37.16M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $9.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $18.58M derived: sum of 2 quarters · filed 2025-03-03 | $27.52M derived: sum of 3 quarters · filed 2025-03-03 | $36.14M 10-K · filed 2025-03-03 | ||
| 2022-09-30 | $9.14M 10-Q · filed 2023-11-08 | $18.08M derived: sum of 2 quarters · filed 2023-11-08 | $26.70M 10-Q · filed 2023-11-08 | $35.16M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $8.94M 10-Q · filed 2023-08-09 | $17.56M 10-Q · filed 2023-08-09 | $26.02M derived: sum of 3 quarters · filed 2024-02-29 | $34.38M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $8.62M 10-Q · filed 2023-05-05 | $17.09M derived: sum of 2 quarters · filed 2024-02-29 | $25.44M derived: sum of 3 quarters · filed 2024-02-29 | $33.70M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $8.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $16.82M derived: sum of 2 quarters · filed 2024-02-29 | $25.08M derived: sum of 3 quarters · filed 2024-02-29 | $33.19M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $8.35M 10-Q · filed 2022-11-08 | $16.61M derived: sum of 2 quarters · filed 2022-11-08 | $24.72M 10-Q · filed 2022-11-08 | $32.99M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $8.26M 10-Q · filed 2022-08-08 | $16.37M 10-Q · filed 2022-08-08 | $24.64M derived: sum of 3 quarters · filed 2023-02-28 | $32.33M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $8.11M 10-Q · filed 2022-05-09 | $16.38M derived: sum of 2 quarters · filed 2023-02-28 | $24.07M derived: sum of 3 quarters · filed 2023-02-28 | $30.63M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $8.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $15.96M derived: sum of 2 quarters · filed 2023-02-28 | $22.52M derived: sum of 3 quarters · filed 2023-02-28 | $30.31M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $7.70M 10-Q · filed 2021-11-09 | $14.25M derived: sum of 2 quarters · filed 2021-11-09 | $22.04M 10-Q · filed 2021-11-09 | $36.73M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $6.55M 10-Q · filed 2021-08-09 | $14.35M 10-Q · filed 2021-08-09 | $29.03M derived: sum of 3 quarters · filed 2021-08-09 | $36.72M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | $7.79M 10-Q · filed 2021-05-10 | $22.48M derived: sum of 2 quarters · filed 2021-05-10 | $30.16M derived: sum of 3 quarters · filed 2021-05-10 | $37.85M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $14.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $22.37M derived: sum of 2 quarters · filed 2021-03-01 | $30.06M derived: sum of 3 quarters · filed 2021-03-01 | $30.08M 10-K · filed 2021-03-01 | ||
| 2019-09-30 | $7.69M 10-Q · filed 2020-11-06 | $7.19M 10-Q · filed 2019-11-08 | $15.37M derived: sum of 2 quarters · filed 2020-11-06 | $15.39M 10-Q · filed 2020-11-06 | $22.58M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $7.69M 10-Q · filed 2020-08-07 | $15.39M 10-Q · filed 2020-08-07 | ||||
| 2019-03-31 | $7.71M 10-Q · filed 2020-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |